Central Pharmaceutical Joint Stock Company No3 (HNX: DP3)
Health Care · Pharmaceuticals · VN
₫61,200.00
+0.99% today · +15.7% 1Y
Central Pharmaceutical Joint Stock Company No3 (HNX: DP3) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $50.83M.
Over the last twelve months the share price has gained 15.7%, trading between 47.00K and 67.50K.
Tweenvest scores Central Pharmaceutical Joint Stock Company No3 across four factors: quality 82/100, value 64/100, growth 84/100, dividend 91/100. Its strongest factor is dividend.
DP3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.83M
- Revenue (TTM)
- $19.59M
- P/E
- 7.56
- EPS
- 8,091.45
- Dividend yield
- 6.54%
- Beta (5Y)
- 0.41
- 52-week high
- ₫67,500.00
- 52-week low
- ₫47,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hyperion DeFi, Inc.NasdaqCM: HYPD | $52.83M | $3.48 | +2.35% |
| Ferozsons Laboratories LimitedKASE: FEROZ | $51.53M | PKRs328.26 | -3.61% |
| Enzychem Lifesciences CorporationKOSDAQ: A183490 | $51.50M | ₩— | — |
| May & Baker Nigeria plcNGSE: MAYBAKER | $50.86M | ₦39.20 | -5.08% |
| Sinsin Pharmaceutical Co., LtdKOSDAQ: A002800 | $50.44M | ₩4,470.00 | +0.34% |
| Sareum Holdings plcAIM: SAR | $50.33M | £0.28 | -8.33% |
| Infinium Pharmachem LimitedNSEI: INFINIUM | $50.32M | Rs312.50 | -0.56% |
| Orion Pharma LimitedDSE: ORIONPHARM | $49.78M | Tk26.20 | -9.66% |
Figures last refreshed Oct 11, 2026.